Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anticoagulant Reversal Strategies in the Emergency Department Setting: Recommendations of a Multidisciplinary Expert Panel.
Baugh CW, Levine M, Cornutt D, Wilson JW, Kwun R, Mahan CE, Pollack CV Jr, Marcolini EG, Milling TJ Jr, Peacock WF, Rosovsky RP, Wu F, Sarode R, Spyropoulos AC, Villines TC, Woods TD, McManus J, Williams J. Baugh CW, et al. Among authors: sarode r. Ann Emerg Med. 2020 Oct;76(4):470-485. doi: 10.1016/j.annemergmed.2019.09.001. Epub 2019 Nov 13. Ann Emerg Med. 2020. PMID: 31732375 Free PMC article.
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R. Goldstein JN, et al. Among authors: sarode r. Lancet. 2015 May 23;385(9982):2077-87. doi: 10.1016/S0140-6736(14)61685-8. Epub 2015 Feb 27. Lancet. 2015. PMID: 25728933 Free PMC article. Clinical Trial.
Thromboembolic Events After Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate: Exploratory Analyses of Two Randomized, Plasma-Controlled Studies.
Milling TJ Jr, Refaai MA, Goldstein JN, Schneider A, Omert L, Harman A, Lee ML, Sarode R. Milling TJ Jr, et al. Among authors: sarode r. Ann Emerg Med. 2016 Jan;67(1):96-105.e5. doi: 10.1016/j.annemergmed.2015.04.036. Epub 2015 Jun 17. Ann Emerg Med. 2016. PMID: 26094105 Free PMC article.
Safety of a Four-factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials.
Milling TJ Jr, Refaai MA, Sarode R, Lewis B, Mangione A, Durn BL, Harman A, Lee ML, Goldstein JN. Milling TJ Jr, et al. Among authors: sarode r. Acad Emerg Med. 2016 Apr;23(4):466-75. doi: 10.1111/acem.12911. Epub 2016 Mar 21. Acad Emerg Med. 2016. PMID: 26822172 Free PMC article. Clinical Trial.
Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials.
Refaai MA, Kothari TH, Straub S, Falcon J, Sarode R, Goldstein JN, Brainsky A, Omert L, Lee ML, Milling TJ. Refaai MA, et al. Among authors: sarode r. Emerg Med Int. 2017;2017:8024356. doi: 10.1155/2017/8024356. Epub 2017 Sep 19. Emerg Med Int. 2017. PMID: 29057123 Free PMC article.
231 results